Our Story
Our Vision
To be recognized in the market as the Solution Provider of Choice for clinical diagnostic testing. Our relentless customer advocacy guides us to develop and deliver complete solutions to our customers’ daily challenges of managing patient’s health in a changing delivery environment.
Purpose Built
MedTest Dx was purpose built to be the Solution Provider of Choice for clinical diagnostic testing. We offer a unique combination of screening instruments, reagent manufacturing, world class service capabilities and full LC/MS toxicology confirmation products.
We are a globally recognized reagent manufacturing organization meeting scientific and regulatory needs as well as a service organization with an impeccable reputation in chemistry, toxicology, and hematology.
We provide reliable, scalable, state of the art, low cost instrumentation that meets the needs of customers with restrictive budgets.
We challenge ourselves every day with the question – “What Would our Customers Want?” Through this relentless customer advocacy, we strive to deliver the best solutions to customers’ daily challenges.
Our Brands
MedTest Dx
Improving clinical testing turnaround time
High throughput clinical analyzers with
broad test menus, including general chemistries and Drugs of Abuse along with small sample volume hematology analyzers
Pointe Brand
The premier general chemistry
reagent manufacturer in the US
Open channel and instrument specific
general chemistry assays manufactured
in an FDA regulated environment
Clinitox Solutions
Your quality control partner for
confirmation testing
Supporting method installation & training while providing ready-to-use LC/MS calibrators and controls
MedLab Solutions
Enhancing your service
experience
Decreasing clinical laboratory instrumentation downtime with
our nationwide and highly experienced field service team
Leadership Team
Wayne Brinster
Chief Executive Officer
Doug Harris
Vice President of Sales
Ron Jamison
Vice President of Operations
Tracy Neri Luciano
Vice President of Marketing
Lenell Wyche
Chief Financial Officer
